XML 136 R117.htm IDEA: XBRL DOCUMENT v3.23.3
Note 14 - Net Loss Per Share - Schedule of Net Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Net loss $ (17,619) $ (14,823) $ (47,470) $ (22,944) $ (36,641) $ (96,305) $ (21,529)
Basic weighted-average common shares outstanding (in shares) 89,739,310 89,002,430 89,476,065 81,221,550 83,188,276 [1] 16,655,634 [1],[2] 16,029,826 [1],[2]
Basic loss per share for the period attributable to common stockholders (in dollars per share) $ (0.2) $ (0.17) $ (0.53) $ (0.28) $ (0.44) $ (5.78) [2] $ (1.34) [2]
Adjustment to numerator - Change in fair value of Columbia Warrant liability $ 0 $ (18,635) $ 0 $ (18,635) $ (18,635) $ 0 $ 0
Dilutive numerator $ (17,619) $ (33,458) $ (47,470) $ (41,579) $ (55,276) $ (96,305) $ (21,529)
Columbia Warrant (in shares) 0 1,410,657 0 1,410,657 609,873 0 0
Diluted weighted-average common shares outstanding (in shares) 89,739,310 90,413,087 89,476,065 82,632,207 83,798,149 16,655,634 [2] 16,029,826 [2]
Diluted loss per share for the period attributable to common stockholders (in dollars per share) $ (0.2) $ (0.37) $ (0.53) $ (0.5) $ (0.66) $ (5.78) [2] $ (1.34) [2]
[1] After applying the 3.3028 Exchange Ratio as described in Note 4 (Reverse Recapitalization).
[2] The change in net loss in the adoption of U.S. GAAP as described in items a-d above impacted net loss per share as follows: